Jeremy Kortmansky, MD < Yale School of ...

Dr. Jeremy S. Kortmansky

Claim this profile

Yale University

Studies Colon Cancer
Studies Rectal Cancer
6 reported clinical trials
18 drugs studied

Area of expertise

1

Colon Cancer

Jeremy S. Kortmansky has run 5 trials for Colon Cancer. Some of their research focus areas include:

Stage III
Stage IV
BRAF negative
2

Rectal Cancer

Jeremy S. Kortmansky has run 2 trials for Rectal Cancer. Some of their research focus areas include:

Stage IV
Stage III
BRAF negative

Affiliated Hospitals

Image of trial facility.

Yale University

Image of trial facility.

Yale-New Haven Hospital North Haven Medical Center

Clinical Trials Jeremy S. Kortmansky is currently running

More about Jeremy S. Kortmansky

Clinical Trial Related

8 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Jeremy S. Kortmansky has experience with

  • Cetuximab
  • Irinotecan Hydrochloride
  • Pertuzumab
  • Trastuzumab
  • Savolitinib
  • Capecitabine

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Jeremy S. Kortmansky specialize in?

Is Jeremy S. Kortmansky currently recruiting for clinical trials?

Are there any treatments that Jeremy S. Kortmansky has studied deeply?

What is the best way to schedule an appointment with Jeremy S. Kortmansky?

What is the office address of Jeremy S. Kortmansky?

Is there any support for travel costs?